Institution identification

PURI

https://redirect.ema.europa.eu/resource/49637

Institution ID

49637

Institution full name and acronym

Global Database Studies, IQVIA

Institution countries

Czechia
Finland
Germany
Slovakia
Spain

Type of institution

Other

Institution website

ENCePP partner

Yes
Institution description
IQVIA is a leading global provider of advanced analytics,technology solutions and clinical research services to the life sciences industry dedicated to creating intelligent connections that deliver unique innovations and actionable insights. As part of IQVIA,Global Database Studies (GloDaSt) specialises in provision of Real World Evidence (RWE) studies and high quality pharmacoepidemiology research. We utilise Real World Data from various health registries with patient-level information on drug prescriptions,diagnoses,treatments and outcomes. Our offerings include feasibility studies,post-authorisation safety studies,drug utilisation studies and relative effectiveness studies. Our methodology combines clinical,pharmacological,epidemiological and statistical knowledge.
Institution details
Experience with collecting data directly from individual patients or respondents:
Yes
Interest in carrying out research that is funded by pharmaceutical companies:
Yes

Contact

Studies conducted by the institution

A multinational active safety surveillance study of crizotinib in Europe and the United States
A Non-Interventional Multi-Database Post-Authorisation Study to Assess Pregnancy-Related Safety Data from Women with Severe Asthma Exposed to Tezepelumab (TREATY)
A non-interventional study to examine patient characteristics and drug utilization patterns in migraine patients treated with prophylactic drugs in Nordic countries
A Population-based Cohort Study of Pregabalin to Characterize Pregnancy Outcomes
A real-world observational study of treatment patterns and outcomes for patients with neuromyelitis optica spectrum disorders (NMOSD) treated with inebilizumab (UPLIZNA) in Europe
A Retrospective Cohort Study for Estimating Incidence Rates of Infusion Site Events for ABBV-951 for the Treatment of Advanced Parkinson's Disease
Drug utilization study of mirabegron (Betmiga®) using real-world healthcare databases from the Netherlands, Spain, United Kingdom and Finland (Mirabegron DUS)
Effectiveness of inhaled treprostinil versus standard of care for the treatment of pulmonary hypertension associated with interstitial lung disease: A propensity score-weighted study of the INCREASE trial and registry data from Europe
Extrapyramidal symptoms in patients treated with Abilify Maintena®: Cohort study with a 2-year follow-up using European automated healthcare databases
Pan European Multi-Database Bladder Cancer Risk Characterisation Study
Real-World Comparative Effectiveness Study of TYVASO (Inhaled Treprostinil) in the Treatment of PH-ILD